US Stock MarketDetailed Quotes

STOK Stoke Therapeutics

Watchlist
  • 12.240
  • -0.020-0.16%
Close Sep 27 16:00 ET
  • 12.500
  • +0.260+2.12%
Post 16:10 ET
644.41MMarket Cap-5640P/E (TTM)

Stoke Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
19.83%-17.48M
-15.03%-24.57M
-154.40%-81.07M
7.71%-20.65M
21.74%-17.26M
-9.39%-21.8M
-165.73%-21.36M
52.37%-31.87M
-37.61%-22.37M
-50.22%-22.06M
Net income from continuing operations
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
6.01%-24.54M
-24.35%-30.65M
8.54%-22.55M
-17.79%-101.07M
-4.94%-25.66M
-15.55%-26.11M
Operating gains losses
----
----
--1K
--0
----
----
----
----
----
----
Depreciation and amortization
-10.31%548K
-5.70%563K
59.70%2.47M
2.46%624K
64.18%637K
102.32%611K
141.70%597K
58.73%1.55M
159.15%609K
52.76%388K
Other non cash items
1.08%562K
0.00%550K
13.62%2.26M
8.84%591K
5.04%563K
4.32%556K
45.89%550K
58.36%1.99M
40.67%543K
66.46%536K
Change In working capital
-102.80%-30K
20.18%-4.69M
-114.02%-6.03M
75.06%-875K
86.97%-351K
151.56%1.07M
-111.45%-5.88M
93,428.26%43.02M
-224.17%-3.51M
-200.64%-2.69M
-Change in prepaid assets
-136.22%-644K
83.29%-349K
110.21%529K
188.55%1.35M
-188.47%-514K
283.11%1.78M
36.05%-2.09M
-81.80%-5.18M
-96.40%-1.53M
154.82%581K
-Change in payables and accrued expense
180.80%3.58M
-646.72%-1.92M
9.12%-3.21M
-677.39%-1.15M
249.85%2.02M
-517.64%-4.43M
110.19%351K
-221.85%-3.53M
-94.48%199K
-154.98%-1.35M
-Change in other working capital
-179.61%-2.96M
41.47%-2.42M
-106.48%-3.35M
50.50%-1.08M
3.84%-1.85M
271.52%3.72M
-107.14%-4.14M
--51.74M
---2.18M
---1.93M
Cash from discontinued investing activities
Operating cash flow
19.83%-17.48M
-15.03%-24.57M
-154.40%-81.07M
7.71%-20.65M
21.74%-17.26M
-9.39%-21.8M
-165.73%-21.36M
52.37%-31.87M
-37.61%-22.37M
-50.22%-22.06M
Investing cash flow
Cash flow from continuing investing activities
-476.08%-88.28M
-81.18%9.99M
330.91%105.95M
-34.32%14.77M
-78.27%14.62M
15,977.40%23.47M
139.10%53.09M
39.97%-45.88M
90.64%22.49M
1,377.81%67.26M
Net PPE purchase and sale
94.52%-46K
92.73%-12K
59.21%-1.62M
44.01%-229K
81.13%-383K
-23.02%-839K
80.38%-165K
-230.17%-3.96M
-101.48%-409K
-643.59%-2.03M
Net investment purchase and sale
-462.92%-88.23M
-81.22%10M
356.59%107.56M
-34.49%15M
-78.35%15M
2,836.23%24.31M
139.46%53.25M
44.27%-41.92M
90.83%22.9M
1,488.38%69.29M
Cash from discontinued investing activities
Investing cash flow
-476.08%-88.28M
-81.18%9.99M
330.91%105.95M
-34.32%14.77M
-78.27%14.62M
15,977.40%23.47M
139.10%53.09M
39.97%-45.88M
90.64%22.49M
1,377.81%67.26M
Financing cash flow
Cash flow from continuing financing activities
251,254.17%120.65M
-96.19%1.72M
14.22%53.01M
16,976.74%7.34M
29.49%562K
-98.60%48K
5.99%45.05M
3,514.41%46.41M
-74.85%43K
6.37%434K
Net common stock issuance
--119.88M
-97.10%1.3M
14.86%52.08M
--7.34M
--0
--0
5.91%44.74M
--45.34M
--0
--0
Proceeds from stock option exercised by employees
1,495.83%766K
34.41%418K
-12.97%926K
-88.10%5K
29.49%562K
-85.28%48K
18.70%311K
-17.26%1.06M
-75.58%42K
6.63%434K
Net other financing activities
----
----
----
----
----
----
----
150.00%1K
----
----
Cash from discontinued financing activities
Financing cash flow
251,254.17%120.65M
-96.19%1.72M
14.22%53.01M
16,976.74%7.34M
29.49%562K
-98.60%48K
5.99%45.05M
3,514.41%46.41M
-74.85%43K
6.37%434K
Net cash flow
Beginning cash position
-6.16%179.15M
68.25%192.01M
-21.54%114.13M
67.20%190.55M
181.94%192.63M
125.45%190.91M
-21.54%114.13M
-49.41%145.46M
-23.90%113.97M
-59.64%68.32M
Current changes in cash
765.49%14.9M
-116.75%-12.86M
348.53%77.89M
815.63%1.47M
-104.56%-2.08M
110.52%1.72M
226.32%76.78M
77.94%-31.34M
103.73%160K
333.61%45.64M
End cash Position
0.74%194.05M
-6.16%179.15M
68.25%192.01M
68.25%192.01M
67.20%190.55M
181.94%192.63M
125.45%190.91M
-21.54%114.13M
-21.54%114.13M
-23.90%113.97M
Free cash flow
22.60%-17.52M
-14.20%-24.58M
-130.78%-82.68M
8.36%-20.88M
26.74%-17.65M
-9.84%-22.64M
-168.00%-21.52M
47.39%-35.83M
-38.40%-22.78M
-61.06%-24.09M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 19.83%-17.48M-15.03%-24.57M-154.40%-81.07M7.71%-20.65M21.74%-17.26M-9.39%-21.8M-165.73%-21.36M52.37%-31.87M-37.61%-22.37M-50.22%-22.06M
Net income from continuing operations 16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M6.01%-24.54M-24.35%-30.65M8.54%-22.55M-17.79%-101.07M-4.94%-25.66M-15.55%-26.11M
Operating gains losses ----------1K--0------------------------
Depreciation and amortization -10.31%548K-5.70%563K59.70%2.47M2.46%624K64.18%637K102.32%611K141.70%597K58.73%1.55M159.15%609K52.76%388K
Other non cash items 1.08%562K0.00%550K13.62%2.26M8.84%591K5.04%563K4.32%556K45.89%550K58.36%1.99M40.67%543K66.46%536K
Change In working capital -102.80%-30K20.18%-4.69M-114.02%-6.03M75.06%-875K86.97%-351K151.56%1.07M-111.45%-5.88M93,428.26%43.02M-224.17%-3.51M-200.64%-2.69M
-Change in prepaid assets -136.22%-644K83.29%-349K110.21%529K188.55%1.35M-188.47%-514K283.11%1.78M36.05%-2.09M-81.80%-5.18M-96.40%-1.53M154.82%581K
-Change in payables and accrued expense 180.80%3.58M-646.72%-1.92M9.12%-3.21M-677.39%-1.15M249.85%2.02M-517.64%-4.43M110.19%351K-221.85%-3.53M-94.48%199K-154.98%-1.35M
-Change in other working capital -179.61%-2.96M41.47%-2.42M-106.48%-3.35M50.50%-1.08M3.84%-1.85M271.52%3.72M-107.14%-4.14M--51.74M---2.18M---1.93M
Cash from discontinued investing activities
Operating cash flow 19.83%-17.48M-15.03%-24.57M-154.40%-81.07M7.71%-20.65M21.74%-17.26M-9.39%-21.8M-165.73%-21.36M52.37%-31.87M-37.61%-22.37M-50.22%-22.06M
Investing cash flow
Cash flow from continuing investing activities -476.08%-88.28M-81.18%9.99M330.91%105.95M-34.32%14.77M-78.27%14.62M15,977.40%23.47M139.10%53.09M39.97%-45.88M90.64%22.49M1,377.81%67.26M
Net PPE purchase and sale 94.52%-46K92.73%-12K59.21%-1.62M44.01%-229K81.13%-383K-23.02%-839K80.38%-165K-230.17%-3.96M-101.48%-409K-643.59%-2.03M
Net investment purchase and sale -462.92%-88.23M-81.22%10M356.59%107.56M-34.49%15M-78.35%15M2,836.23%24.31M139.46%53.25M44.27%-41.92M90.83%22.9M1,488.38%69.29M
Cash from discontinued investing activities
Investing cash flow -476.08%-88.28M-81.18%9.99M330.91%105.95M-34.32%14.77M-78.27%14.62M15,977.40%23.47M139.10%53.09M39.97%-45.88M90.64%22.49M1,377.81%67.26M
Financing cash flow
Cash flow from continuing financing activities 251,254.17%120.65M-96.19%1.72M14.22%53.01M16,976.74%7.34M29.49%562K-98.60%48K5.99%45.05M3,514.41%46.41M-74.85%43K6.37%434K
Net common stock issuance --119.88M-97.10%1.3M14.86%52.08M--7.34M--0--05.91%44.74M--45.34M--0--0
Proceeds from stock option exercised by employees 1,495.83%766K34.41%418K-12.97%926K-88.10%5K29.49%562K-85.28%48K18.70%311K-17.26%1.06M-75.58%42K6.63%434K
Net other financing activities ----------------------------150.00%1K--------
Cash from discontinued financing activities
Financing cash flow 251,254.17%120.65M-96.19%1.72M14.22%53.01M16,976.74%7.34M29.49%562K-98.60%48K5.99%45.05M3,514.41%46.41M-74.85%43K6.37%434K
Net cash flow
Beginning cash position -6.16%179.15M68.25%192.01M-21.54%114.13M67.20%190.55M181.94%192.63M125.45%190.91M-21.54%114.13M-49.41%145.46M-23.90%113.97M-59.64%68.32M
Current changes in cash 765.49%14.9M-116.75%-12.86M348.53%77.89M815.63%1.47M-104.56%-2.08M110.52%1.72M226.32%76.78M77.94%-31.34M103.73%160K333.61%45.64M
End cash Position 0.74%194.05M-6.16%179.15M68.25%192.01M68.25%192.01M67.20%190.55M181.94%192.63M125.45%190.91M-21.54%114.13M-21.54%114.13M-23.90%113.97M
Free cash flow 22.60%-17.52M-14.20%-24.58M-130.78%-82.68M8.36%-20.88M26.74%-17.65M-9.84%-22.64M-168.00%-21.52M47.39%-35.83M-38.40%-22.78M-61.06%-24.09M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data